3D Systems Management

Management criteria checks 1/4

3D Systems' CEO is Jeff Graves, appointed in May 2020, has a tenure of 4.5 years. total yearly compensation is $6.54M, comprised of 13% salary and 87% bonuses, including company stock and options. directly owns 0.77% of the company’s shares, worth €3.19M. The average tenure of the management team and the board of directors is 1.9 years and 7.4 years respectively.

Key information

Jeff Graves

Chief executive officer

US$6.5m

Total compensation

CEO salary percentage13.0%
CEO tenure4.5yrs
CEO ownership0.8%
Management average tenure1.9yrs
Board average tenure7.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jeff Graves's remuneration changed compared to 3D Systems's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$348m

Mar 31 2024n/an/a

-US$350m

Dec 31 2023US$7mUS$850k

-US$363m

Sep 30 2023n/an/a

-US$96m

Jun 30 2023n/an/a

-US$122m

Mar 31 2023n/an/a

-US$126m

Dec 31 2022US$6mUS$850k

-US$123m

Sep 30 2022n/an/a

-US$104m

Jun 30 2022n/an/a

US$227m

Mar 31 2022n/an/a

US$250m

Dec 31 2021US$9mUS$837k

US$322m

Sep 30 2021n/an/a

US$308m

Jun 30 2021n/an/a

-US$57m

Mar 31 2021n/an/a

-US$85m

Dec 31 2020US$6mUS$489k

-US$150m

Compensation vs Market: Jeff's total compensation ($USD6.54M) is above average for companies of similar size in the German market ($USD1.03M).

Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.


CEO

Jeff Graves (63 yo)

4.5yrs

Tenure

US$6,535,630

Compensation

Dr. Jeffrey Alan Graves, also known as Jeff, is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is P...


Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Graves
President4.5yrsUS$6.54m0.77%
€ 3.2m
Reji Puthenveetil
Executive Vice President of Industrial Solutions4.3yrsUS$2.31m0.27%
€ 1.1m
Jeffrey Creech
Executive VPless than a yearUS$845.99k0.13%
€ 548.4k
Phyllis Nordstrom
Executive VP3.3yrsUS$2.10m0.12%
€ 509.5k
Charles Hull
Co-Founderno datano data0.43%
€ 1.8m
Joseph Zuiker
Executive Vice President of Engineering & Operations1.9yrsno data0.11%
€ 469.2k
Michael McCloskey
Treasurer & VP of Investor Relationsno datano datano data
Andrew Wright
Senior VP of General Counsel & Corporate Secretaryless than a yearno datano data
Harriss Currie
President - Regenerative Medicineless than a yearno data0.096%
€ 396.4k

1.9yrs

Average Tenure

60.5yo

Average Age

Experienced Management: SYV's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jeffrey Graves
President4.8yrsUS$6.54m0.77%
€ 3.2m
Charles Hull
Co-Founderno datano data0.43%
€ 1.8m
Jim Kever
Independent Director28.8yrsUS$220.00k0.36%
€ 1.5m
Thomas Erickson
Independent Director9yrsUS$228.76k0.24%
€ 990.7k
Kevin Moore
Independent Director25.1yrsUS$245.00k0.18%
€ 750.2k
Charles McClure
Independent Chairman of the Board7.7yrsUS$400.00k0.11%
€ 473.3k
William Curran
Independent Director16.8yrsUS$255.00k0.11%
€ 440.6k
John Tracy
Independent Director7.4yrsUS$240.00k0.11%
€ 468.9k
Stephen Klasko
Chair of Medical Advisory Board2.5yrsno datano data
Malissia Clinton
Independent Director5.7yrsUS$240.00k0.094%
€ 389.2k
Vasant Padmanabhan
Independent Director3.9yrsUS$216.24k0.088%
€ 365.2k
Claudia Drayton
Independent Director2.9yrsUS$218.11k0.075%
€ 307.9k

7.4yrs

Average Tenure

70yo

Average Age

Experienced Board: SYV's board of directors are considered experienced (7.4 years average tenure).